Recommended NZ | Guide to Money | Gimme: Competitions - Giveaways

Cancer Control Agency's latest report is a missed opportunity - BCF

Contributor:
Fuseworks Media
Fuseworks Media

Responding to the Cancer Control Agency’s latest report on the funding of cancer drugs in Aotearoa (embargoed to 28 April), Ah-Leen Rayner, chief executive of Breast Cancer Foundation NZ, said:

"This is a timely report, given we are awaiting the overdue findings of the Pharmac review. It’s a good start, but unfortunately it won’t bring any comfort to the Kiwi breast cancer patients who are fighting for the treatment they need.

"Te Aho of Te Kahu’s analysis identifies just one single breast cancer drug available to Australians that Kiwis can’t access. We know of at least one other that’s been approved across the Tasman recently, and in total, 15 unfunded breast cancer drugs meet the high benefit threshold used in Te Aho’s report. They’re available in other countries and are recommended in international treatment guidelines. When we’re hearing from oncologists urgently wanting to prescribe drugs they believe will work for their patients who have no other options, this report is nothing but a missed opportunity to fully ‘Understand the Gap’."

All articles and comments on Voxy.co.nz have been submitted by our community of users. Please notify us if you believe an item on this site breaches our community guidelines.